๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Biliary Tract Cancer (BTC)
Clinical trial register · China

Biliary Tract Cancer (BTC) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 5 Beijing 4 Chengdu 1 Tianjin 1 Wuhan 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai5 Beijing4 Chengdu1 Tianjin1 Wuhan1
All 5 locations
Target enrolment
to

Biliary Tract Cancer (BTC) trials in China

13 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors
NCT07726446Biliary Tract Cancer (BTC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
30
Tianjin
2026-10
Not yet open
Cryoablation Combined With QL1706 (Iparomlimab/Tuvonralimab) Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer.
NCT07829874Biliary Tract Cancer (BTC)
Fudan University
Phase 2
180
Shanghai
2026-09-20
Recruiting
Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma
NCT07786766Biliary Tract Cancer (BTC)
Haitao Zhao, MD
Phase 2
154
Beijing
2026-08-20
Recruiting
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
NCT07763301Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC)
West China Hospital
Phase 1
9
Chengdu
2026-08-01
Recruiting
QL1706๏ผˆIparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer
NCT07733115Biliary Tract Cancer (BTC)
Shanghai Zhongshan Hospital
Phase 2
38
Shanghai
2026-07-20
Not yet open
Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer
NCT07638501Biliary Tract Cancer (BTC)
Eastern Hepatobiliary Surgery Hospital
Phase 2
123
Shanghai
2026-06-15
Recruiting
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
NCT07466238Biliary Tract Cancer (BTC)
Peking University
Not applicable
40
Beijing
2026-03-31
Not yet open
Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer
NCT07169916Biliary Tract Cancer (BTC)
Fudan University
Not applicable
210
Shanghai
2025-09-01
Not yet open
A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen
NCT07099794Biliary Tract Cancer (BTC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
90
Beijing
2025-08-01
Active, closed
Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer
NCT07159204Biliary Tract Cancer (BTC)
Peking Union Medical College Hospital
Phase 2
61
Beijing
2024-08-07
Active, closed
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
NCT05036486Biliary Tract Cancer (BTC)
National Health Research Institutes, Taiwan
Observational
480
2021-10-25
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/biliary-tract-cancer-btc

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies listing the condition Biliary Tract Cancer (BTC).

How many Biliary Tract Cancer (BTC) trials are recruiting in China?

6 of the 13 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Biliary Tract Cancer (BTC)), 13 studies
PhaseStudiesRecruitingShare
Phase 28361.5%
Not applicable2115.4%
Observational107.7%
Phase 1117.7%
Phase 4117.7%

Most active sponsors

Lead sponsors with the most studies (Biliary Tract Cancer (BTC))
Lead sponsorStudiesRecruiting
Fudan University30
Cancer Institute and Hospital, Chinese Academy of Medical Sciences10
Eastern Hepatobiliary Surgery Hospital10
Haitao Zhao, MD11
National Health Research Institutes, Taiwan10
Peking Union Medical College Hospital10
Peking University11
Shanghai Zhongshan Hospital11
Tianjin Medical University Cancer Institute and Hospital11
West China Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.